Observation of the clinical efficacy of thyroxine assisted therapy for elderly chronic severe heart failure
甲状腺素辅助治疗老年慢性重症心力衰竭的临床疗效观察

摘要

目的 探析老年慢性重症心力衰竭患者行甲状腺素辅助治疗的效果。方法 此次研究对象源自本院2022年2月-2023年2月期间收治的52例老年慢性重症心力衰竭患者。依照治疗方法不同分为常规组（药物治疗；n=26）、试验组（甲状腺素辅助治疗；n=26）。以临床疗效、甲状腺水平指标验证2组效果。结果 临床疗效显示试验组显高（P＜0.05）。甲状腺水平显示，试验组显优（P＜0.05）。结论 老年慢性重症心力衰竭患者行甲状腺素辅助治疗效果确切，可促进临床疗效，改善甲状腺水平。

Abstract

Objective To explore the effect of thyroid hormone adjuvant therapy on elderly patients with chronic severe heart failure.
Methods The study subjects were 52 elderly patients with severe chronic heart failure admitted to our hospital from February 2022 to February 2023. According to different treatment methods, they were divided into a conventional group (drug therapy; n=26) and an experimental group (thyroid hormone adjuvant therapy; n=26). Validate the efficacy of two groups based on clinical efficacy and thyroid level indicators.
Results Clinical efficacy showed a significant increase in the experimental group (P<0.05). Thyroid levels showed that the experimental group showed significant improvement (P<0.05).
Conclusion   Thyroxine adjuvant therapy is effective in elderly patients with chronic severe heart failure, promoting clinical efficacy and improving thyroid levels.